Clinical Trial Update: Safety, Tolerability, Pharmacokinetics(PK), Pharmacodynamics(PD) and Food Effect of HRS9950 in Healthy and CHB Subjects [Phase 1]

View source ↗

Summary

Phase 1 study evaluating safety, tolerability, pharmacokinetics/pharmacodynamics, and the effect of food on HRS9950 in healthy volunteers and patients with chro…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• HRS9950 (HRS9950)

Snippet

Sponsor: Jiangsu HengRui Medicine Co., Ltd. | Conditions: Chronic Hepatitis b | Phase 1 | Status: COMPLETED